J. Safra Sarasin Holding AG Buys 17,640 Shares of Xylem Inc. $XYL

J. Safra Sarasin Holding AG raised its stake in Xylem Inc. (NYSE:XYL) by 5.6% in the 1st quarter, HoldingsChannel.com reports. The firm owned 332,132 shares of the industrial products company’s stock after buying an additional 17,640 shares during the quarter. J. Safra Sarasin Holding AG’s holdings in Xylem were worth $39,632,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Board of the Pension Protection Fund bought a new stake in Xylem during the fourth quarter worth $27,000. Commonwealth Retirement Investments LLC bought a new position in Xylem during the 4th quarter valued at $27,000. Wexford Capital LP bought a new position in Xylem during the 3rd quarter valued at $27,000. Global Assets Advisory LLC purchased a new position in Xylem during the 1st quarter worth $40,000. Finally, FWL Investment Management LLC purchased a new position in Xylem during the 2nd quarter worth $43,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Xylem Trading Up 0.0%

NYSE XYL opened at $121.26 on Monday. The business’s fifty day moving average is $112.64 and its 200-day moving average is $123.94. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.46 and a quick ratio of 1.10. The stock has a market capitalization of $28.82 billion, a price-to-earnings ratio of 30.16, a PEG ratio of 1.72 and a beta of 1.03. Xylem Inc. has a one year low of $105.29 and a one year high of $154.27.

Xylem (NYSE:XYL) last posted its quarterly earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, beating the consensus estimate of $1.09 by $0.03. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The company had revenue of $2.12 billion during the quarter, compared to analyst estimates of $2.11 billion. During the same quarter in the prior year, the business earned $1.03 earnings per share. The firm’s revenue for the quarter was up 2.7% on a year-over-year basis. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. Equities research analysts predict that Xylem Inc. will post 5.51 EPS for the current year.

Xylem Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Thursday, May 28th were given a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date of this dividend was Thursday, May 28th. Xylem’s dividend payout ratio is currently 42.79%.

Analyst Ratings Changes

Several analysts have recently commented on XYL shares. CLSA upgraded shares of Xylem to a “hold” rating in a report on Thursday, June 25th. Oppenheimer cut their price target on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating on the stock in a report on Wednesday, April 29th. UBS Group upped their price objective on shares of Xylem from $132.00 to $133.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 29th. Barclays decreased their price objective on shares of Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a research note on Wednesday, April 29th. Finally, Stifel Nicolaus cut their target price on Xylem from $163.00 to $159.00 and set a “buy” rating on the stock in a research note on Wednesday, April 29th. Eight investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $153.54.

Insider Activity at Xylem

In related news, Director Jerome A. Peribere purchased 1,210 shares of the firm’s stock in a transaction dated Monday, May 4th. The stock was bought at an average price of $116.61 per share, for a total transaction of $141,098.10. Following the purchase, the director directly owned 27,209 shares in the company, valued at approximately $3,172,841.49. This trade represents a 4.65% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of Xylem stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total transaction of $501,436.74. Following the completion of the sale, the chief accounting officer directly owned 3,605 shares in the company, valued at $423,443.30. This trade represents a 54.22% decrease in their position. The SEC filing for this sale provides additional information. Company insiders own 0.32% of the company’s stock.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.